HeartFlowHTFL -8.94%12 Debt-to-EBITDA is -0.24 as of Mar. 2026. GuruFocus rates HTFL with a GF Score™ of 12/100. The stock has 3 warning signs investors should review. Among 475 Healthcare Providers & Services companies, HeartFlow ranks worse than 210526.11% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for HeartFlow's Debt-to-EBITDA or its related term are showing as below:
HTFL'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: -2.56 Med: -2.45 Max: -0.24
Current: -0.28
During the past 3 years, the highest Debt-to-EBITDA Ratio of HeartFlow was -0.24. The lowest was -2.56. And the median was -2.45.
HTFL's Debt-to-EBITDA is ranked worse than 100% of 475
companies
in the Healthcare Providers & Services industry
Industry Median: 2.21
vs HTFL: -0.28
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
HeartFlow Debt-to-EBITDA Related Terms
HeartFlow Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for HeartFlow's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HTFL vs PRVA, WAY, DOCS: Debt-to-EBITDA Comparison
For the Health Information Services subindustry, HeartFlow's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HeartFlow Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, HeartFlow's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where HeartFlow's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
HeartFlow (HTFL) has a Debt-to-EBITDA of -0.24 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on HeartFlow. According to the industry distribution chart, HeartFlow ranks #999999 out of 475 companies in the Healthcare Providers & Services industry.
Is HeartFlow's Debt-to-EBITDA too high?
HeartFlow's current Debt-to-EBITDA is -0.24. Based on the distribution chart, HeartFlow ranks #999999 out of 475 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, HeartFlow has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does HeartFlow's Debt-to-EBITDA compare to PRVA and WAY?
According to the Healthcare Providers & Services industry distribution chart, HeartFlow ranks #999999 out of 475 companies for Debt-to-EBITDA. This places HeartFlow in the lower half of its industry. The industry median Debt-to-EBITDA is 2.21. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.21, based on 475 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on HeartFlow. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HeartFlow's current Debt-to-EBITDA is -0.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HeartFlow stock overvalued right now?
HeartFlow (HTFL) has a current Debt-to-EBITDA of -0.24. The current Debt-to-EBITDA is -0.24. HeartFlow's overall GF Score™ is 12/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For HeartFlow (HTFL), the current Debt-to-EBITDA is -0.24 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.
12GF Score
Get the complete analysis for HTFL
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HTFL has been successfully added to your 
